CYP39A1
CYP39A1 (cytochrome P450 family 39 subfamily A member 1) is an endoplasmic reticulum cytochrome P450 monooxygenase, also named 24-hydroxycholesterol 7-alpha-hydroxylase. It contributes to neural cholesterol clearance by converting oxysterols towards bile acids. Browse Assay Genie's current range of CYP39A1 research reagents below, or read on for the biology behind the target.
CYP39A1 is a cytochrome P450 monooxygenase involved in neural cholesterol clearance through bile acid synthesis. It catalyses 7-alpha hydroxylation of (24S)-hydroxycholesterol, a neural oxysterol that is metabolised to bile acids in the liver. Mechanistically, the enzyme uses molecular oxygen, inserting one oxygen atom into the substrate and reducing the second to a water molecule. The two electrons required are provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase).
The CYP39A1 gene encodes a member of the cytochrome P450 superfamily. These monooxygenases catalyse many reactions involved in drug metabolism and in the synthesis of cholesterol, steroids and other lipids. The CYP39A1 protein is located in the endoplasmic reticulum and microsome membranes, and is involved in the conversion of cholesterol to bile acids. Its substrates include the oxysterols 25-hydroxycholesterol, 27-hydroxycholesterol and 24-hydroxycholesterol. Alternate splicing of the gene results in multiple transcript variants. The mouse ortholog is Cyp39a1.
HGNC places CYP39A1 in the cytochrome P450 family 39 gene group. Earlier names were cytochrome P450, subfamily XXXIX (oxysterol 7 alpha-hydroxylase), polypeptide 1, and cytochrome P450, family 39, subfamily A, polypeptide 1. These names reflect its activity towards oxysterols, which makes it a useful reference point for researchers studying oxysterol metabolism and bile acid biosynthesis.
CYP39A1 is involved in the conversion of cholesterol to bile acids, making it relevant to studies of hepatic oxysterol metabolism.
The enzyme contributes to neural cholesterol clearance by hydroxylating (24S)-hydroxycholesterol, a neural oxysterol later metabolised to bile acids in the liver.
Substrates include 24-hydroxycholesterol, 25-hydroxycholesterol and 27-hydroxycholesterol, so CYP39A1 is a focus for work on oxysterol handling.
CYP39A1 relies on NADPH and cytochrome P450 reductase for electrons, serving as a model for P450 monooxygenase mechanism and lipid metabolism.
CYP39A1 is a cytochrome P450 monooxygenase that catalyses 7-alpha hydroxylation of (24S)-hydroxycholesterol, a neural oxysterol that is metabolised to bile acids in the liver. In this way it supports neural cholesterol clearance through bile acid synthesis, using NADPH-derived electrons from cytochrome P450 reductase.
The UniProt protein name is 24-hydroxycholesterol 7-alpha-hydroxylase, and the enzyme carries EC number 1.14.14.26. Earlier HGNC names include cytochrome P450, subfamily XXXIX (oxysterol 7 alpha-hydroxylase), polypeptide 1. NCBI notes that alternate splicing produces multiple transcript variants.
A mouse ortholog, Cyp39a1, is recorded for the human CYP39A1 gene, so the enzyme can be studied in mouse models. No rat ortholog is listed in the data used here. Check the datasheet of any product for its validated reactivity.
Other cytochrome P450 enzymes, including sterol-metabolising and steroidogenic family members, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NYL5; product specifications from Assay Genie datasheets.